Michael Gould to Lung Neoplasms
This is a "connection" page, showing publications Michael Gould has written about Lung Neoplasms.
Connection Strength
23.208
-
The American Cancer Society National Lung Cancer Roundtable strategic plan: Optimizing strategies for lung nodule evaluation and management. Cancer. 2024 Dec 15; 130(24):4177-4187.
Score: 0.744
-
Inappropriate Determinations of Inappropriateness for Lung Cancer Screening. Am J Respir Crit Care Med. 2024 Jan 15; 209(2):130-131.
Score: 0.708
-
Is Lung Cancer Screening Reaching the People Who Are Most Likely to Benefit? JAMA Netw Open. 2022 11 01; 5(11):e2243171.
Score: 0.651
-
Facilitating Adherence to Annual Screening for Lung Cancer: Are Program-Level Interventions Enough? Chest. 2022 07; 162(1):8-10.
Score: 0.636
-
Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study. BMJ Open. 2022 06 22; 12(6):e064142.
Score: 0.635
-
Guidelines for the Evaluation of Pulmonary Nodules Detected Incidentally or by Screening: A Survey of Radiologist Awareness, Agreement, and Adherence From the Watch the Spot Trial. J Am Coll Radiol. 2021 Apr; 18(4):545-553.
Score: 0.569
-
Methods for the Watch the Spot Trial. A Pragmatic Trial of More- versus Less-Intensive Strategies for Active Surveillance of Small Pulmonary Nodules. Ann Am Thorac Soc. 2019 12; 16(12):1567-1576.
Score: 0.532
-
Monitoring Lung Cancer Screening Use and Outcomes at Four Cancer Research Network Sites. Ann Am Thorac Soc. 2017 Dec; 14(12):1827-1835.
Score: 0.463
-
Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer. Ann Am Thorac Soc. 2017 Oct; 14(10):1571-1580.
Score: 0.458
-
Multilevel Barriers to the Successful Implementation of Lung Cancer Screening: Why Does It Have to Be So Hard? Ann Am Thorac Soc. 2017 Aug; 14(8):1261-1265.
Score: 0.453
-
Invasive Mediastinal Staging in Lung Cancer. Use a Prediction Model or Just Do It? Am J Respir Crit Care Med. 2017 06 15; 195(12):1556-1558.
Score: 0.449
-
The Importance of Being Adaptable: Developing Guidelines for Lung Nodule Evaluation in Asia. Chest. 2016 10; 150(4):763-765.
Score: 0.427
-
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74.
Score: 0.425
-
Surveillance Imaging in Patients with Resected Non-Small Cell Lung Cancer: Too Much, Not Enough, or Just Right? Ann Am Thorac Soc. 2016 09; 13(9):1446-7.
Score: 0.425
-
The five commandments of efficient and effective care in the initial evaluation of lung cancer. Curr Opin Pulm Med. 2016 07; 22(4):319-26.
Score: 0.420
-
Who Should Be Screened for Lung Cancer? And Who Gets to Decide? JAMA. 2016 Jun 07; 315(21):2279-81.
Score: 0.418
-
Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign. Chest. 2016 Apr; 149(4):943-50.
Score: 0.406
-
Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study. Ann Am Thorac Soc. 2016 Jan; 13(1):58-66.
Score: 0.406
-
Lung Cancer Screening in Individuals with Chronic Obstructive Pulmonary Disease. Finding the Sweet Spot. Am J Respir Crit Care Med. 2015 Nov 01; 192(9):1027-8.
Score: 0.401
-
Clinical practice. Lung-cancer screening with low-dose computed tomography. N Engl J Med. 2014 Nov 06; 371(19):1813-20.
Score: 0.374
-
Lung cancer screening and elderly adults: do we have sufficient evidence? Ann Intern Med. 2014 Nov 04; 161(9):672-3.
Score: 0.374
-
Facility-level analysis of PET scanning for staging among US veterans with non-small cell lung cancer. Chest. 2014 Apr; 145(4):839-847.
Score: 0.359
-
Facility characteristics and quality of lung cancer care in an integrated health care system. J Thorac Oncol. 2014 Apr; 9(4):447-55.
Score: 0.359
-
Accuracy of clinicians and models for estimating the probability that a pulmonary nodule is malignant. Ann Am Thorac Soc. 2013 Dec; 10(6):629-35.
Score: 0.351
-
Response. Chest. 2013 Nov; 144(5):1742.
Score: 0.349
-
Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e121S-e141S.
Score: 0.337
-
Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e93S-e120S.
Score: 0.337
-
Favorable stage distribution in the NELSON trial: promise or hype? Am J Respir Crit Care Med. 2013 Apr 15; 187(8):792-3.
Score: 0.336
-
When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med. 2012 Oct 16; 157(8):571-3.
Score: 0.325
-
Automated identification of patients with pulmonary nodules in an integrated health system using administrative health plan data, radiology reports, and natural language processing. J Thorac Oncol. 2012 Aug; 7(8):1257-62.
Score: 0.320
-
The use and misuse of positron emission tomography in lung cancer evaluation. Clin Chest Med. 2011 Dec; 32(4):749-62.
Score: 0.306
-
Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study. J Thorac Oncol. 2011 May; 6(5):875-83.
Score: 0.293
-
Evaluation of screening-detected lung nodules: minimising the risk of unnecessary biopsy and surgery. Thorax. 2011 Apr; 66(4):277-9.
Score: 0.290
-
Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review. J Thorac Oncol. 2009 Dec; 4(12):1473-9.
Score: 0.266
-
Delays in lung cancer care: time to improve. J Thorac Oncol. 2009 Nov; 4(11):1303-4.
Score: 0.265
-
Timeliness of care in patients with lung cancer: a systematic review. Thorax. 2009 Sep; 64(9):749-56.
Score: 0.262
-
Hospital characteristics associated with timeliness of care in veterans with lung cancer. Am J Respir Crit Care Med. 2009 Apr 01; 179(7):595-600.
Score: 0.246
-
Timeliness across the continuum of care in veterans with lung cancer. J Thorac Oncol. 2008 Sep; 3(9):951-7.
Score: 0.244
-
Variation in experts' beliefs about lung cancer growth, progression, and prognosis. J Thorac Oncol. 2008 Apr; 3(4):422-6.
Score: 0.237
-
Timeliness of care in veterans with non-small cell lung cancer. Chest. 2008 May; 133(5):1167-73.
Score: 0.235
-
Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules. Thorax. 2008 Apr; 63(4):335-41.
Score: 0.230
-
Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):108S-130S.
Score: 0.228
-
CT screening for lung cancer. N Engl J Med. 2007 Feb 15; 356(7):743; author reply 746-7.
Score: 0.219
-
A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest. 2007 Feb; 131(2):383-8.
Score: 0.219
-
A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer. J Thorac Oncol. 2006 Nov; 1(9):953-9.
Score: 0.215
-
When in doubt should we cut it out? The role of surgery in non-small cell lung cancer. Thorax. 2006 Jul; 61(7):554-6.
Score: 0.210
-
Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis. Thorax. 2005 Nov; 60(11):949-55.
Score: 0.196
-
Multidisciplinary management of lung cancer. N Engl J Med. 2004 May 06; 350(19):2008-10; author reply 2008-10.
Score: 0.181
-
Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med. 2003 Dec 02; 139(11):879-92.
Score: 0.176
-
Research Priorities for Interventions to Address Health Disparities in Lung Nodule Management: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2023 03 15; 207(6):e31-e46.
Score: 0.167
-
Lung cancer screening debate. Chest. 2003 Feb; 123(2):653-4; author reply 654-5.
Score: 0.166
-
The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study. PLoS One. 2022; 17(11):e0263911.
Score: 0.163
-
Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study. Ann Intern Med. 2022 11; 175(11):1501-1505.
Score: 0.162
-
Fleischner Society Guideline Recommendations for Incidentally Detected Pulmonary Nodules and the Probability of Lung Cancer. J Am Coll Radiol. 2022 Nov; 19(11):1226-1235.
Score: 0.161
-
Stakeholder Research Priorities to Promote Implementation of Shared Decision-Making for Lung Cancer Screening: An American Thoracic Society and Veterans Affairs Health Services Research and Development Statement. Am J Respir Crit Care Med. 2022 03 15; 205(6):619-630.
Score: 0.156
-
Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 2001 Feb 21; 285(7):914-24.
Score: 0.145
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest. 2020 07; 158(1):406-415.
Score: 0.137
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. J Am Coll Radiol. 2020 Jul; 17(7):845-854.
Score: 0.137
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Radiol Imaging Cancer. 2020 05; 2(3):e204013.
Score: 0.137
-
Safely and Effectively Evaluating Computed Tomography-detected Lung Lesions. Much Work to Be Done. Ann Am Thorac Soc. 2019 11; 16(11):1360-1362.
Score: 0.132
-
Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor-related Pneumonitis. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2019 09 15; 200(6):e31-e43.
Score: 0.131
-
Managing solitary pulmonary nodules: accurate predictions and divergent conclusions. Mayo Clin Proc. 1999 Apr; 74(4):435-6.
Score: 0.127
-
Strategy and cost in investigating solitary pulmonary nodules. Thorax. 1998 Aug; 53 Suppl 2:S32-7.
Score: 0.121
-
Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2017 11 01; 196(9):1202-1212.
Score: 0.115
-
Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement. Am J Respir Crit Care Med. 2017 10 01; 196(7):e15-e29.
Score: 0.114
-
Lung cancer. Curr Opin Pulm Med. 1997 Jul; 3(4):243-6.
Score: 0.113
-
Radiotherapy for brain metastases near the end of life in an integrated health care system. Ann Palliat Med. 2017 Aug; 6(Suppl 1):S28-S38.
Score: 0.111
-
Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270.
Score: 0.109
-
Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment. J Clin Oncol. 2016 11 20; 34(33):3984-3991.
Score: 0.107
-
Deploying Team Science Principles to Optimize Interdisciplinary Lung Cancer Care Delivery: Avoiding the Long and Winding Road to Optimal Care. J Oncol Pract. 2016 11; 12(11):983-991.
Score: 0.107
-
Depression symptom trends and health domains among lung cancer patients in the CanCORS study. Lung Cancer. 2016 10; 100:102-109.
Score: 0.106
-
Use of [(18)F]Fluoro-2-deoxy-d-glucose Positron Emission Tomographic Imaging in the National Lung Screening Trial. Chest. 2016 09; 150(3):621-30.
Score: 0.104
-
Systems-Level Resources for Pulmonary Nodule Evaluation in the United States: A National Survey. Am J Respir Crit Care Med. 2016 05 01; 193(9):1063-5.
Score: 0.104
-
Patients' Knowledge, Beliefs, and Distress Associated with Detection and Evaluation of Incidental Pulmonary Nodules for Cancer: Results from a Multicenter Survey. J Thorac Oncol. 2016 05; 11(5):700-708.
Score: 0.103
-
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414.
Score: 0.101
-
Recent Trends in the Identification of Incidental Pulmonary Nodules. Am J Respir Crit Care Med. 2015 Nov 15; 192(10):1208-14.
Score: 0.101
-
An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med. 2015 Oct 01; 192(7):881-91.
Score: 0.100
-
An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management. Am J Respir Crit Care Med. 2015 Aug 15; 192(4):500-14.
Score: 0.099
-
Reply: Lung Cancer Screening: The Balance between Harm and Benefit. Am J Respir Crit Care Med. 2015 May 15; 191(10):1209-10.
Score: 0.097
-
Attitudes about low-dose computed tomography screening for lung cancer: a survey of American Thoracic Society Clinicians. Am J Respir Crit Care Med. 2015 Feb 15; 191(4):483-6.
Score: 0.095
-
Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest. 2015 Feb; 147(2):295-303.
Score: 0.095
-
Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33.
Score: 0.095
-
Resource use and guideline concordance in evaluation of pulmonary nodules for cancer: too much and too little care. JAMA Intern Med. 2014 Jun; 174(6):871-80.
Score: 0.091
-
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest. 2014 Mar 01; 145(3):464-472.
Score: 0.089
-
Computed tomography screening for lung cancer. Ann Intern Med. 2013 Jul 16; 159(2):155-6.
Score: 0.086
-
Patient preference and contraindications in measuring quality of care: what do administrative data miss? J Clin Oncol. 2013 Jul 20; 31(21):2716-23.
Score: 0.085
-
Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e211S-e250S.
Score: 0.084
-
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012 Jun 13; 307(22):2418-29.
Score: 0.079
-
Decision making in patients with pulmonary nodules. Am J Respir Crit Care Med. 2012 Feb 15; 185(4):363-72.
Score: 0.076
-
Lung cancer stage at diagnosis: Individual associations in the prospective VITamins and lifestyle (VITAL) cohort. BMC Cancer. 2011 Jun 07; 11:228.
Score: 0.074
-
An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes. Am J Respir Crit Care Med. 2010 Nov 01; 182(9):1195-205.
Score: 0.071
-
PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. Chest. 2010 May; 137(5):1150-6.
Score: 0.067
-
Cost and outcomes of patients with solitary pulmonary nodules managed with PET scans. Chest. 2010 01; 137(1):53-9.
Score: 0.064
-
Minimally invasive techniques for the diagnosis of peripheral pulmonary nodules. Curr Opin Pulm Med. 2008 Jul; 14(4):282-6.
Score: 0.060
-
Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):149S-160S.
Score: 0.057
-
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):178S-201S.
Score: 0.057
-
Lung cancer incidence in never smokers. J Clin Oncol. 2007 Feb 10; 25(5):472-8.
Score: 0.055
-
Usefulness of positron emission tomography imaging in the management of lung cancer. Curr Opin Pulm Med. 1999 Jul; 5(4):201-7.
Score: 0.032
-
Identification of benign pulmonary nodules by needle biopsy. Chest. 1998 Jan; 113(1):3-5.
Score: 0.029
-
What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest. 2013 Mar; 143(3):672-677.
Score: 0.021
-
'The thing is not knowing': patients' perspectives on surveillance of an indeterminate pulmonary nodule. Health Expect. 2015 Jun; 18(3):355-65.
Score: 0.021
-
A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. J Nucl Med. 2008 Feb; 49(2):179-85.
Score: 0.015
-
Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):94S-107S.
Score: 0.014